Cargando…
Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
Autores principales: | Altschuler, Eric L., Kast, Richard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177090/ https://www.ncbi.nlm.nih.gov/pubmed/32344275 http://dx.doi.org/10.1016/j.mehy.2020.109774 |
Ejemplares similares
-
Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
por: Salehzadeh, Farhad, et al.
Publicado: (2019) -
Contemporary Ventilation Strategies And Adjunctive Therapies For Acute Respiratory Distress Syndrome (Ards)
por: Duan, EH, et al.
Publicado: (2015) -
The Efficacy of Colchicine and Dapsone Combination Therapy in Relapsed Immune Thrombocytopenia
por: Rattanathammethee, Thanawat, et al.
Publicado: (2017) -
Colchicine reduces lung injury in experimental acute respiratory distress syndrome
por: Dupuis, Jocelyn, et al.
Publicado: (2020) -
Kratom-Induced Acute Respiratory Distress Syndrome (ARDS)
por: Chinnappan, Justine, et al.
Publicado: (2023)